Anti–miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response

Document Details

Document Type
Pub Defense Publication
Publication Date
Jul 17, 2023
Source ID
10.1172/jci158348

Entities

People

  • Aiham Qdaisat
  • Anh M. Tran
  • Anh Ton
  • Catalin Vasilescu
  • Constantin Georgescu
  • Cristian Rodriguez-Aguayo
  • Cristina Ivan
  • David Horst
  • Enrique Fuentes-Mattei
  • Erik Knutsen
  • Florea Lupu
  • Gabriel Lopez-berestein
  • George A. Calin
  • Huan-Yu Zhang
  • Ines Koch
  • Katy Rezvani
  • Keishi Okubo
  • Kevin Liu
  • Lan Pang
  • Manuela Ferracin
  • Maria Teresa Sabrina Bertilaccio
  • Masayoshi Shimizu
  • Matthew W. Anderson
  • Mecit Kaplan
  • Melanie Winkle
  • Meng Chen
  • Mihnea Paul Dragomir
  • Pinaki P. Banerjee
  • Rafet Başar
  • Ravi S. Keshari
  • Recep Bayraktar
  • Robert Silasi
  • Sai-Ching Jim Yeung
  • Simone Anfossi
  • Spencer J. Rothfuss
  • Swati Mohapatra
  • Xiuping Liu
  • Yongfeng Li
  • Ziyi Li

Organizations

  • National Cancer Institute
  • National Institute of General Medical Sciences
  • National Institutes of Health
  • Northern Norway Regional Health Authority
  • United States Department of Defense